Publications

5891 Results

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group study [PMID20846714; PMC2978536]

Authors
L Randall-Whitis;BJ Monk;J Moon;R Parker;M Al-Ghazi;S Wilczynski;JP Fruehauf;M Markman;RA Burger
Journal / Conference
Gyncologic Oncology, 119(3):417-421;
Year
2010
Research Committee(s)
Gynecologic
Study Number(s)
S0013

An updated report on the pathologic complete response and survival outcome of Southwest Oncology Group (SWOG S0356): A phase II trial of oxaliplatin (OXP) plus protracted infusion 5-fluorouracil (PIFU) and external beam radiation (EBRT) prior to surgery (S) for potentially curable esophageal adenocarcinoma (EA) with molecular correlates

Authors
L Leichman;B Goldman;C Thomas;K Billingsley;C Corless;H Lenz;S Iqbal;J Benedetti;P Gold;C Blanke
Journal / Conference
American Society of Therapeutic Radiation Oncologists (ASTRO) Annual Meeting; oral
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356

Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): analysis of a Southwest Oncology Group Trial

Authors
V Sanchorawala;V Bolejack;J Crowley;A Hoering;KT Finn;S Fennessey;DC Seldin;B Barlogie
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8022); ASCO 2010 Annual Meeting; poster
Year
2010
Research Committee(s)
Myeloma
Study Number(s)
S0115

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104 [PMID20368559; PMC288173]

Authors
AH Partridge;L Archer;AB Kornblith;J Gralow;D Grenier;E Perez;AC Wolff;X Wang;H Kastrissios;D Berry;C Hudis;E Winer;M Muss
Journal / Conference
Journal of Clinical Oncology 28(14):2418-2422
Year
2010
Research Committee(s)
Breast

Does microgranular variant morphology of acute promyelocytic leukemia independently predict for a less favorable outcome compared with classical M3 APL? A joint study of North American Intergroup and PETHEMA Group [PMID20858857;PMC3031411]

Authors
M Tallman;HT Kim;P Montesinos;F Appelbaum;J de la Serna;JM Bennett;G Deben;C Bloomfield;J Gonzalez;JH Feusner;M Gonzalez;RA Larson;J Gonzalez-San Miguel;A Ogden;G Milone;JM Rowe;C Rayon;L Shepherd;C Rivas;CA Schiffer;E Vallenga;PH Wiernik;CL Willman;MA Sanz
Journal / Conference
Blood 116(25):5650-5659
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Multivitamin use is not associated with cancer recurrence or survival in patients with Stage III colon cancer: findings from CALGB 89803 [PMID20805450; PMC2954134]

Authors
K Ng;JA Meyerhardt;JA Chan;D Niedzwiecki;DR Hollis;LB Saltz;RJ Mayer;AB Benson;PL Schaefer;R Whittom;A Hantel;RM Goldberg;C Fuchs
Journal / Conference
Journal of Clinical Oncology, 28(29):4354-4363;
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy (TRT) as definitive treatment for locally advanced, unresectable esophageal cancer (Ec): a SWOG (S0414) phase II trial

Authors
CR Thomas;B Goldman;J Benedetti;H Lenz;T Beeker;JL Abbruzzese;C Blanke
Journal / Conference
ASCO 2010 Gastrointestinal Cancers Symposium, abst. #72; poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0414

Do mixed histologic features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?

Authors
EM Messing;E Scosyrev;HB Grossman;R de Vere White;DL Trump;RB Natale;C Tangen;ED Crawford;IM Thompson
Journal / Conference
ASCO 2010 Genitourinary Cancers Symposium, abstr. #274; oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therappy (RT) in locally advanced prostate cancer (CAP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)

Authors
PR Warde;MD Mason;MR Sydes;M Gospodarowicz;GP Swanson;P Kirkbride;E Kostashuk;J Hetherington;K Ding;W Parulekar
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr CRA4504); oral presentation
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
JPR3

ECOG 2204: An intergroup phase II study of cetuxamab (Ce) or bevacizumab (B) in combination with gemcitabine (G) and in combination with capecitabine (Ca) and radiation (XRT) as adjuvant therapy (Adj Tx) for patients (pts) with completely resected pancreatic adenocarcinoma (PC)

Authors
J Berlin;PJ Catalano;Y Feng;AM Lowy;AW Blackstock;PA Philip;RR McWilliams;J Abbruzzese;AB Benson
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 4024) poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/E2204